WDM(SH:600055) Xin Lang Zheng Quan·2025-10-30 06:29Core Viewpoint - WanDong Medical's stock price has experienced a decline recently, with a year-to-date increase of 4.68% but a significant drop in the last 5, 20, and 60 trading days [1] Financial Performance - For the period from January to September 2025, WanDong Medical achieved a revenue of 1.189 billion yuan, representing a year-on-year growth of 8.73% [2] - The net profit attributable to the parent company was -27.21 million yuan, a decrease of 123.51% year-on-year [2] Stock Market Activity - As of October 30, WanDong Medical's stock price was 15.67 yuan per share, with a market capitalization of 11.017 billion yuan [1] - The stock saw a net outflow of 8.9691 million yuan in principal funds, with significant selling pressure compared to buying [1] Shareholder Information - As of September 30, 2025, the number of shareholders increased to 27,200, with an average of 25,882 circulating shares per person, a decrease of 1.22% [2] - The top ten circulating shareholders include notable entities such as HuaBao ZhongZheng Medical ETF and Hong Kong Central Clearing Limited, with varying changes in their holdings [3] Dividend Information - Since its A-share listing, WanDong Medical has distributed a total of 769 million yuan in dividends, with 267 million yuan in the last three years [3] Company Overview - WanDong Medical, established on May 12, 1997, specializes in the research, manufacturing, and sales of imaging medical devices, with 90.72% of its revenue coming from medical device sales [1] - The company operates within the pharmaceutical and biological industry, specifically in medical devices [1]